Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Prospective Cohort Study in Patients With Irreversible Biventricular Heart Failure to Assess the Efficacy and Safety of Carmat TAH, Clinical Utility and Cost, as a Bridge to Transplantation

NCT04475393 is registered in ClinicalTrials.gov with Carmat SAS as lead sponsor.

NCT NCT04475393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04475393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Prospective Cohort Study in Patients With Irreversible Biventricular Heart Failure to Assess the Efficacy and Safety of Carmat TAH, Clinical Utility and Cost, as a Bridge to Transplantation
Lead sponsor
Carmat SAS
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 12, 2022
Completion date
April 30, 2027
Enrollment
104 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

advanced heart failure